“Ceftolozane-Tazobatam for Febrile Neutropenia Treatment in Hematologic Malignancy Patients Colonized by Multi-Resistant Enterobacteriaceae: Preliminary Results from a Prospective Cohort Study: Ceftolozane-Tazobatam for Febrile Neutropenia”. Mediterranean Journal of Hematology and Infectious Diseases 12, no. 1 (September 7, 2020): e2020065. Accessed April 29, 2026. https://www.mjhid.org/mjhid/article/view/2020.065.